Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.
2.

Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy.

Stevenson LW.

Circulation. 2003 Jul 29;108(4):492-7. Review. No abstract available.

3.
4.

The value of positive inotropy in acute and chronic heart failure.

Erdmann E.

J Cardiovasc Pharmacol. 1989;14 Suppl 3:S36-41. Review.

PMID:
2478802
5.

Inotropic infusions for chronic congestive heart failure: medical miracles or misguided medicinals?

Ewy GA.

J Am Coll Cardiol. 1999 Feb;33(2):572-5. Review. No abstract available.

6.

Positive inotropic agents in congestive heart failure.

Homoud MK, Chuttani K, Konstam MA.

Coron Artery Dis. 1993 Jan;4(1):44-52. Review. No abstract available.

PMID:
7903591
7.

Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.

Follath F.

Ital Heart J. 2003 May;4 Suppl 2:34S-38S.

PMID:
14635368
8.

Evaluating the efficacy of new inotropic agents.

Braunwald E, Colucci WS.

J Am Coll Cardiol. 1984 Jun;3(6):1570-4. No abstract available.

PMID:
6715715
9.

Pulsed inotropic therapy in chronic congestive heart failure: a review of the literature.

Woods TD, Prisant LM.

Am J Ther. 2000 Nov;7(6):375-80. Review.

PMID:
11304645
10.
11.

Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).

Stevenson LW, Miller LW, Desvigne-Nickens P, Ascheim DD, Parides MK, Renlund DG, Oren RM, Krueger SK, Costanzo MR, Wann LS, Levitan RG, Mancini D; REMATCH Investigators..

Circulation. 2004 Aug 24;110(8):975-81. Epub 2004 Aug 16.

12.

The clinical experience with levosimendan in anesthesiology and in the intensive care unit.

Cavana M, Pignataro C, Fraticelli A, Mebazaa A.

Ital Heart J. 2003 May;4 Suppl 2:61S-64S. Review.

PMID:
14635372
13.
14.

[Application of non-glycoside inotropic agents in newborn infants].

Umans-Eckenhausen MA, Terlouw JF, Szatmari A, van den Anker JN.

Tijdschr Kindergeneeskd. 1993 Feb;61(1):13-20. Review. Dutch.

PMID:
8493697
15.

Inotropic drugs for the treatment of heart failure.

Mancini DM, Keren G, Aogaichi K, LeJemtel TH, Sonnenblick EH.

J Clin Pharmacol. 1985 Oct;25(7):540-54. Review. No abstract available.

PMID:
2866200
16.

Inotropic therapy is unsuccessful: wrong conceptual target or wrong therapeutic tools?

Rapezzi C, Perugini E, Santi M, Bracchetti G, Branzi A.

Ital Heart J. 2003 May;4 Suppl 2:22S-26S. Review.

PMID:
14635366
17.

Advances in positive inotropic therapy: levosimendan.

Frishman WH.

Crit Care Med. 2003 Sep;31(9):2408-9. No abstract available.

PMID:
14501979
18.

Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.

Drakos SG, Kanakakis JV, Nanas S, Bonios M, Kaldara E, Katsaros F, Pantsios C, Nanas JN.

J Cardiovasc Pharmacol. 2009 Feb;53(2):157-61. doi: 10.1097/FJC.0b013e31819846cd.

PMID:
19188832
19.

Novel biologic mechanisms of levosimendan and its effect on the failing heart.

Parissis JT, Andreadou I, Bistola V, Paraskevaidis I, Filippatos G, Kremastinos DT.

Expert Opin Investig Drugs. 2008 Aug;17(8):1143-50. doi: 10.1517/13543784.17.8.1143 . Review.

PMID:
18616411
20.

Levosimendan: beyond its simple inotropic effect in heart failure.

Antoniades C, Tousoulis D, Koumallos N, Marinou K, Stefanadis C.

Pharmacol Ther. 2007 May;114(2):184-97. Epub 2007 Feb 16. Review.

PMID:
17363065

Supplemental Content

Support Center